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Abstract
It was the aim of the present investigation to examine whether the stimulating effect of parathyroid hormone (PTH) on
human periodontal ligament (hPDL) cell proliferation and differentiation would be enhanced by hPDL/T-cell interaction
involving Wnt10b signaling as a mediating pathway. hPDL cells were cultured from healthy premolar tissues of three
adolescent orthodontic patients and exposed to PTH(1-34) in monocultures or co-cultures with CD8+ T cells. At
harvest, proliferation, alkaline phosphatase-specific activity (ALP), and osteocalcin production were determined by
immunofluorescence cytochemistry, real-time PCR, biochemical assay, and ELISA. Wnt10b signaling was analyzed by
the use of a specific WNT10b neutralizing antibody. PTH(1-34) stimulation of T cells significantly increased Wnt10b
expression and production. Wnt10b exposure of hPDL cells enhanced proliferation and differentiation. PDL cells co-
cultured with T cells showed a Wnt10b-dependent regulation of proliferation and differentiation parameters. The
addition of a Wnt10b-neutralizing Ab to the co-culture medium resulted in a significant inhibition of the PTH(1-34)
effect on proliferation, ALP-specific activity, and osteocalcin protein expression. Our findings provide novel insight into
the mechanism of action of PTH on hPDL cells and establish the interplay of T cells and hPDL cells via the Wnt10b
pathway as a modulating factor for the anabolic properties of the hormone in periodontal regeneration.
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Introduction
Parathyroid hormone (PTH) represents a well-estab-
lished anabolic option for the treatment of bony defects
since it was shown to stimulate new bone formation
and improve the microarchitecture of existing bone.1,2
From the rapidly developing ﬁeld of osteoimmunology
it is known that, particularly under inﬂammatory con-
ditions, there is a tight link of regulatory processes
between stromal and immune cells contributing to the
transduction of the PTH eﬀect.3–5 T cells were ﬁrst
implicated to be regulatorily involved in the anabolic
response to PTH by Pettway et al., who demonstrated
that intermittent PTH (iPTH) enhanced bone content
in wild-type mice as opposed to the failure to induce
vertebral bone growth in T-cell-deﬁcient mice.6 Further
experiments using four strains of T-cell-deﬁcient mice
revealed that mice lacking T cells exhibited a blunted
increase in bone formation and trabecular bone volume
in response to iPTH that could be restored by adoptive
transfer of T cells.7 Regarding the mechanism by which
T cells increase the anabolic response to PTH, Wnt10b
secreted by CD8+ T cells upon PTH stimulation has
been suggested to activate the Wnt signaling pathway
to result in enhanced osteoblast diﬀerentiation and life-
span.3,4 By the number of existing types of immune cells
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it has been documented that Wnt10b signaling is most
eﬀective among the CD8+ T-cell population.3,4,7,8 This
implication has been corroborated by the hampered
eﬀect of PTH on bone turnover in T-cell receptor-ß
knockout mice reconstituted with T cells from
Wnt10b knockout mice.7 The analysis of the eﬀects of
PTH on the T-cell production of cytokines that regulate
osteoblast function has revealed that iPTH does not
change the expression of IL-1, 4, 6, 7, and TGF-
ß, but slightly that of TNF-a. Furthermore, an age-
dependent capacity of PTH to inhibit the production
of Wnt inhibitors such as sclerostin was identiﬁed.9
Thus, T-cell-mediated Wnt signaling in osteoblasts
may represent a key mechanism by which PTH
increases bone strength, providing further evidence
for the crucial role of cross-talk pathways between T
cells and mesenchymal cells in the mediation of ana-
bolic eﬀects of PTH.
In recent years, high-ranking publications provided
accumulating evidence for the eﬀectiveness of PTH in
the craniofacial area and even pointed to an increased
susceptibility of those target structures as compared to
other regions of the body.10 These ﬁndings raised the
interest in the applicability of anabolic doses of PTH to
support periodontal regeneration following trauma,
inﬂammatory periodontal disease or orthodontic
tooth movement. Animal experimental work indicated
the capacity of PTH to limit the inﬂammatory inﬁltrate
and also the extent of bone loss in ligature-induced
periodontitis models.11,12 Shirota et al. demonstrated
that reduced bone density and bone-to-implant contact
in ovariectomized rats could be restored by iPTH
administration.13 In a recent clinical study, patients suf-
fering from periodontitis beneﬁtted from daily subcuta-
neous iPTH injections for 6 wk in addition to
periodontal surgery as reﬂected by improved clinical
outcomes, greater resolution of alveolar bone defects
and accelerated osseous wound healing in the oral
cavity.14 Our group contributed to the recognition of
periodontal ligament (PDL) cells as components of the
tooth-supporting apparatus exhibiting osteoblastic
traits and an osteoblast-like response to hormonal
stimulation identifying them as a promising target in
the attempt to support regenerative periodontal pro-
cesses by PTH administration.15–24
Combining these lines of evidence, it was the aim of
the present investigation to address the question of
whether the stimulating eﬀect of PTH is mediated
through a cellular interaction of T cells and stromal
cells in the area of the periodontal ligament. We
hypothesized that CD8+ T cells would aﬀect periodon-
tal remodeling by modulating human PDL (hPDL) cell
proliferation and diﬀerentiation. Furthermore, we
speculated that this cellular interplay would involve
T-cell-induced Wnt10b as a key mediator that could
function as a potential target for the development of
future treatment strategies.
Material and methods
All experimental protocols were reviewed and approved
by the ethics committee of the University of Bonn (ref-
erence number 029/08).
PDL and T-cell culture
hPDL were cultured from the middle third of premolar
roots to avoid contamination with gingival or apical
tissue using the explant method. The three donors
were aged between 12 and 14 yr and showed no clinical
signs of periodontitis. The teeth had been extracted for
orthodontic reasons and with informed written paren-
tal/guardian consent. Cells were cultured in DMEM
containing 10% FBS and 0.5% antibiotics (diluted
from a stock solution containing 5000 U/ml penicillin
and 5000 U/ml streptomycin; Biochrom AG, Germany)
at 37C in an atmosphere of 100% humidity, 5% CO2,
and 95% air. Fifth passage, non-pre-diﬀerentiated cells
were seeded into 24-well plates (n¼ 6) at a density of
10,000 cells/well and cultured to subconﬂuence
(70%). This seeding protocol was applied to immuno-
cytochemistry, LRP5, alkaline phosphatase (ALP) and
osteocalcin assays. Deviating seeding densities are
detailed below. Prior to experimental use, hPDL cells
were characterized by real-time PCR as described pre-
viously17 and demonstrated to express several markers
typical of cells of mesenchymal origin, including ALP,
osteocalcin, TGF-ß, bone morphogenetic protein
(BMP)-2 and BMP-4.
For T-cell experiments, cells from three diﬀerent
donors were extracted from buﬀy coats using a CD8+
extraction kit (Stemcell Technologies, Grenoble,
France) resulting in 65% CD8+ T cells veriﬁed by
ﬂow cytometry (Beckman Coulter, Germany)
(Figure 1). Cells were cultured in Roswell Park
Memorial Institute (RPMI)1640 medium containing
the same supplements as stated for hPDL cells above.
Effect of PTH(1-34) stimulation of T cells on
Wnt10b expression
In a ﬁrst step, T cells were stimulated with 109 M
PTH(1-34) (Sigma Aldrich, Germany) for 48h prior to
determination of Wnt10b protein expression in the con-
ditioned media by means of a commercially available
ELISA kit speciﬁc for human Wnt10b (Ho¨lzel
Diagnostika, Germany) according to the manufacturer’s
instructions. Changes in Wnt10b mRNA expression
were analyzed by real-time PCR as described below.
Wnt10b effect on hPDL cell proliferation
Next, to examine the eﬀect of Wnt10b on hPDL cell
proliferation, the Wnt10b receptor LRP5 was demon-
strated in hPDL cells by means of RT-PCR and
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immunﬂuorescence cytochemistry as detailed previ-
ously15 and below, respectively. Thereafter, hPDL
cells were stimulated with 50 ng/ml Wnt10b protein
(GenWay-Biotech, USA) for 3 d. Vehicle-treated cul-
tures (H2O) served as controls. A commercially avail-
able MTS assay (Promega, Germany) was carried out
according to the manufacturer’s instructions to meas-
ure cell proliferation rate. In these experiments, the
seeding density was 20,000 cells/well.
Influence of Wnt10b on osteoblastic differentiation
of hPDL cells
Likewise, for proliferation, the impact of Wnt10b on
hPDL cell diﬀerentiation was quantiﬁed at the tran-
scriptional and protein level for ALP-speciﬁc activity
as a marker for early and osteocalcin for late osteo-
blastic diﬀerentiation.
Real-time PCR
PTH(1-34)-induced changes in Wnt10b mRNA expression
by T cells and Wnt10b-induced alterations in osteogenic
marker gene expression in hPDL cells (seeding density for
hPDL cells: 30,000 cells/well in six-well plates; T cells:
10000 cells/wells in 24-well plates) were analyzed by real-
time PCR as described previously.25 The primer sequences
used were as follows: ALP sense 50-AGA-GAA-AGC-G
AT-GGT-GGA-TG-30, antisense 50-CGG-TGG-CAT-TA
A-TAG-TGA-GAT-G-30,26 osteocalcin sense 50-ATG-AG
A-GCC-CTC-ACA-CTC-CTC-G-30, antisense 50-GTC-A
GC-CAA-CTC-GTC-ACA-GTC-C-30; LRP5 sense 5’-A
CC-GGA-ACC-ACG-TCA-CAG-3’, antisense 5’-GGG-
TGG-ATA-GGG-GTC-TGA-GT-3’,27 Wnt10b sense 5’-
GCA-CTG-TAT-TGC-TCC-TCC-CAC-TT-3’; antisense
5’-ATA-GGG-ACT-CCC-CAG-CCA-AA-3’. b-actin was
used as an endogenous reference; sense: 50-CAT-GGA-
TGA-TGA-TAT-CGC-CGC-G-30, antisense: 50-ACA-
TGA-TCT-GGG-TCA-TCT-TCT-CG-30.
ALP protein expression
Following Wnt10b exposure for 48h, hPDL cells were
released from the culture surface by trypsinization at
37C for 10min. This reaction was terminated by the
addition of DMEM containing 10% FBS. Thereafter,
the cell suspension was centrifuged and the cell pellet
resuspended in 0.01% TritonX-100. Changes in ALP-
speciﬁc activity were measured in lysates of isolated cells
as a function of release of paranitrophenol from parani-
trophenylphosphate at pH 10.2 as described previously.28
To ensure that changes in ALP activity did not simply
result from changes in proliferation or apoptosis rather
than from direct eﬀects of Wnt10b, ALP data were cal-
culated as a function of the protein content of the sample.
Osteocalcin protein expression
The level of osteocalcin in the conditioned media after
48 h of Wnt10b stimulation was assayed using a com-
mercially available ELISA kit speciﬁc for human osteo-
calcin (IBL GmbH, Germany) according to the
manufacturer’s instructions.
Immunofluorescence cytochemistry
To visualize the eﬀect of Wnt10b on hPDL cell diﬀer-
entiation along the osteoblastic pathway, immunocyto-
chemical staining was performed using either a 1:50
(40 mg/ml) working dilution of the primary Ab for
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Figure 1. Basal and PTH(1-34)-stimulated Wnt10b expression in CD8+ T cells compared to hPDL cells. (a) Flow cytometry veri-
fication of CD8+ T-cell extraction from human buffy coats (red: CD8+ T cells 65%). (b) Basal Wnt10b mRNA expression by T cells
was enhanced significantly by 109 M PTH(1-34) exposure for 48 h. (c) Wnt10b protein expression was enhanced following 109 M
PTH(1-34) administration. In contrast, basal Wnt10b expression and production was not altered by PTH(1-34) in hPDL cell mono-
cultures (b, c). Data were acquired from one of two separate experiments, both yielding comparable results. Each value is the
mean SD for six independent cultures. *P< 0.05, experimental group vs. vehicle control.
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ALP (rabbit anti-human; Quartett, Germany) or 1:25
(80 mg/ml) for osteocalcin (rabbit anti-human; Biozol,
Germany) in combination with a secondary ﬂuores-
cence-labeled (Cy-3) Ab (1:100 (1.5 mg/ml) working
dilution; goat anti-rabbit; Invitrogen, Germany) and
analyzed microscopically as reported previously.29
Negative controls were run by (i) omitting the primary
Ab, (ii) omitting the primary and secondary Ab and
using TBS/BSA instead, and (iii) by substituting the
primary Ab by an unspeciﬁc IgG. The same protocol
was followed for detection of LRP5 in hPDL cells using
a monoclonal rabbit anti-human Ab (Cell Signaling
Technology Europe, The Netherlands) using a 1:100
(20 mg/ml) working dilution.
Co-culture experiments
To address the question of whether the interaction of
hPDL and immune cells enhances the PDL cell response
to PTH(1-34) via Wnt10b, experimental groups were
stimulated with either 109M PTH(1-34) alone or in
combination with 500ng/ml monoclonal Wnt10b Ab
for 5 d (mouse anti-human, R&D Systems, Germany).
Cell culture medium was changed on d 2. At harvest,
supernatants were collected and stored at 80C until
further analysis. Changes in ALP and osteocalcin pro-
tein expression were quantiﬁed as described above.
To determine the eﬀect on hPDL cell proliferation,
cells were washed with PBS and images of green ﬂuor-
escent hPDL cells were captured at a magniﬁcation of
40 using a ﬂuorescent microscope (Zeiss, Germany).
Cell number was counted using the freeware ImageJ
(National Institutes of Health, Bethesda, MD, USA).
Data from the co-culture experiments were compared
to the ﬁndings in hPDL cell monocultures that were
exposed to 109 M PTH(1-34) for 48 h prior to the
analysis of proliferation, ALP and osteocalcin mRNA
expression and protein production as described above.
Statistical analysis
Each data point represents the mean SD of six independ-
ent cultures per experimental group. Data were analyzed
by analysis of variance (ANOVA) and statistical signiﬁ-
cance determined using Bonferroni’s modiﬁcation of
Student’s t-test for multiple comparisons or the Wilcoxon
test. P-values< 0.05 were considered to be signiﬁcant. The
data are representative of two replicate experiments that
both yielded similar results. Only one set of results from the
two sets of experiments are presented.
Results
Effect of PTH (1-34) on CD8+ T cells
CD8+ T-cell isolation from human blood samples resulted
in a 65% CD8+ T-cell suspension (Figure 1a). In a ﬁrst
step, the basal expression of Wnt10b in CD8+ T cells and
its inducibility by PTH(1-34) were tested both at the tran-
scriptional and protein level. At both levels, a basal
Wnt10b expression in isolated human CD8+ T cells
could be observed. Wnt10b mRNA expression was signiﬁ-
cantly increased (1.5-fold) upon 109 M PTH(1-34)
stimulation for 6h (Figure 1b). Similar to the transcrip-
tional data, Wnt10b protein expression was signiﬁcantly
enhanced compared to untreated controls (Figure 1c).
Effect of PTH(1-34) on hPDL cell monocultures
In contrast to the ﬁndings in CD8+ T cells, the basal
Wnt10b mRNA and protein expression was signiﬁ-
cantly lower in hPDL cells and not altered by 109 M
PTH(1-34) (Figure 1b and c). However, proliferation,
ALP-speciﬁc activity and osteocalcin production were
all enhanced signiﬁcantly following PTH(1-34) expos-
ure of the monocultures (Figure 4).
Verification of Wnt10b signaling receptor
in hPDL cells
To provide evidence that hPDL cells carry the neces-
sary receptor for Wnt10b signaling, the expression of
LRP5 as an important receptor for Wnt10b was
demonstrated by RT-PCR analysis (data not shown)
and immunoﬂuorescence cytochemistry (Figure 2).
Effect of Wnt10b on hPDL cells
To prove that Wnt10b signaling is able to regulate
important parameters associated with regeneration of
the PDL, the isolated eﬀect of Wnt10b on hPDL cells
was analyzed in vitro. Following stimulation of hPDL
cells with a concentration of 50 ng/ml Wnt10b protein,
hPDL cell proliferation rate was enhanced by 30%
compared to untreated controls (Figure 3). Similar to
cell proliferation, early osteogenic diﬀerentiation par-
ameters also were aﬀected. Regarding ALP mRNA, a
(a) (b)
50µm 50µm
Figure 2. Documentation of the presence of the Wnt10b
receptor LRP5 in human PDL cells. Immunofluorescence staining
using a Cy3-labelled secondary antibody confirmed the presence
of the protein in hPDL cells (left panel); negative control was
carried out by omitting the primary antibody and using TBS/BSA
instead (right panel); magnification 40.
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2.5-fold increase could be observed (Figure 4a). A simi-
lar eﬀect was demonstrated for ALP protein produc-
tion. Compared to untreated controls, Wnt10b
stimulation induced a 50% increase in ALP-speciﬁc
activity (Figure 4b). Likewise, ALP, osteocalcin expres-
sion, as a marker of late osteoblastic diﬀerentiation,
was signiﬁcantly increased at the mRNA and protein
level following Wnt10b stimulation (Figure 4c and d).
Those quantitative data on mRNA and protein expres-
sion corroborated the visual impression obtained by
immunoﬂuorescence staining, where Wnt10b stimula-
tion resulted in an enhanced ALP and osteocalcin
immunoreactivity compared to control cultures
(Figure 4c and f).
Wnt10b-dependent regulation of T-cell and
hPDL-cell interaction
To test the physiological relevance of T-cell-released
Wnt10b on hPDL-cell behavior and its enhancement
following PTH stimulation, the observed ﬁndings of
cell monocultures were transferred to a T-cell/hPDL-
cell co-culture system.
Compared to the observations in hPDL-cell mono-
cultures, the co-culture experiments revealed an
increase in cell number and basal expression of both
diﬀerentiation parameters. Likewise, an enhanced
hPDL-cell sensitivity to PTH regarding the cellular
response to T-cell-expressed Wnt10b and its eﬀect on
PDL-cell proliferation and diﬀerentiation was
observed. Following PTH(1-34) stimulation, an
increase in the number of cells as well as in ALP activity
and osteocalcin protein expression was demonstrated.
To provide further evidence for Wnt10b regulation
of the observed phenomena, a speciﬁc neutralizing Ab
raised against Wnt10b was added to the co-culture
medium. Following Wnt10b Ab challenge, the increase
in proliferation, ALP-speciﬁc activity and osteocalcin
expression seen upon 109 M PTH(1-34) stimulation
was inhibited signiﬁcantly or even leveled out at control
levels (Figure 5a–c).
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Figure 3. Wnt10b stimulates the proliferation of hPDL cells.
Human PDL cells were exposed to 50 ng/ml Wnt10b for 3 d
prior to quantification of the proliferation rate by MTS assay.
Data were acquired from one of two separate experiments, both
yielding comparable results. Each value is the mean SD for 6
independent cultures. *P< 0.05, experimental group vs. vehicle
control.
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Figure 4. Effect of Wnt10b on alkaline phosphatase specific activity and osteocalcin expression in hPDL cells. The addition of
50 ng/ml Wnt10b to the culture medium for 3 d resulted in a significant increase in ALP mRNA (a) and protein expression (b) as
determined by realtime PCR and biochemical assay. Immunocytochemical staining confirmed the quantitative data (c), magnification
40. Similar results were obtained for osteocalcin expression (e) and production (e,f). Data were acquired from one of two
separate experiments, both yielding comparable results. Each value is the mean  SD for 6 independent cultures. *P< 0.05,
experimental group vs. vehicle control.
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Discussion
The present study examined the interplay of hPDL cells
and T cells regarding the anabolic response of hPDL
cells to PTH and demonstrated an enhanced hPDL-cell
sensitivity to hormonal stimulation in co-culture with
respect to proliferation and diﬀerentiation as compared
to PTH challenge of monocultures. Furthermore,
Wnt10b was identiﬁed as a mechanistic link to mediate
and amplify the PTH eﬀect.
The PDL hosts a heterogeneous cell population ran-
ging from cells with stem cell character to terminally
diﬀerentiated epithelial cells, osteoblasts, cementoblasts
and ﬁbroblasts.30,31 The latter have been reported to
share osteoblast-like traits and respond accordingly to
hormonal stimulation.32,33 PDL cells were shown to
express the PTH 1 receptor (1R)29 and respond to ana-
bolic doses of PTH with changes of many crucial cell
functions including proliferation, diﬀerentiation, apop-
tosis, and the production of key molecules of bone
remodeling.15–17 These ﬁndings are in line with the
data obtained here in the monoculture experiments
regarding proliferation and diﬀerentiation and
strengthen the view of PDL cells as important regula-
tors of periodontal remodeling. The detection of LRP5
in hPDL cells as one of the receptors for Wnt ligand
binding indicates the cells’ ability to process Wnt sig-
nals and is supported by previous reports in PDL
cells.34–36 Furthermore, it corroborates the osteoblast-
like features of PDL cells and underlines the bidirec-
tional nature of the interaction with immune cells under
inﬂammatory conditions, such as periodontal disease,
trauma or orthodontic tooth movement. Not only do
PDL cells express pro-inﬂammatory cytokines that in
turn mediate the attraction of macrophages to injured
sites,37 but apparently they respond to immune cell sig-
naling via Wnt ligand activation. T-cell-driven Wnt10b
production has been reported to be critical for the acti-
vation of Wnt signaling in osteoblasts and thus crucial
for potentiating the bone anabolic activity of PTH.4 In
the absence of T cells, Terauchi and colleagues reported
on a reduced capacity of PTH to induce stromal cell
commitment to the osteoblastic lineage, osteoblast pro-
liferation and diﬀerentiation, and mitigate osteoblast
apoptosis. All of the anabolic actions of PTH were
attributed to the ability of T cells to activate Wnt sig-
naling in osteoblasts.7 Therefore, we ﬁrst checked the
Wnt10b responsiveness in hPDL cells. Our results with
increased proliferation, ALP-speciﬁc activity and osteo-
calcin production, at both the transcriptional and pro-
tein level, indicate that Wnt10b directs the
diﬀerentiation of hPDL cells along the osteoblastic
pathway. Therefore, it can be concluded that Wnt10b
serves as a mechanistic link in T-cell/PDL cell inter-
action, too. The co-culture experiments we performed
prove that this is indeed the case as evidenced by
increased proliferation and diﬀerentiation of hPDL
cells in the presence of T cells as compared to hPDL-
cell monocultures under unstimulated conditions. The
observation that an addition of Wnt10b Ab at least
partially inhibited the stimulatory eﬀect of T-cell/
PDL-cell interaction further substantiates the above
interpretation. Regarding the mediation of the PTH
eﬀect on hPDL cells, this apparently involves a direct
and an indirect mechanism, with the former being
transduced by the PTH receptor present on the PDL
cell membrane, whereas the indirect eﬀect is mediated
via a PTH-induced enhanced production of Wnt10b by
T cells, which then in turn aﬀects hPDL cell physiology.
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Figure 5. Role of Wnt10b for mediating the interaction of T and hPDL cells. Co-cultures of hPDL cells and CD8+ T cells were
exposed to 10-9 M PTH(1-34) for 5 d in the presence or absence of 500 ng/ml Wnt10b neutralizing antibody. PTH exposure resulted
in an increase of hPDL cell proliferation (a), ALP specific activity (b), and osteocalcin production (c). The addition of a neutralizing
Wnt10b antibody inhibited the PTH effect or even leveled it out at control levels. Data were acquired from one of two separate
experiments, both yielding comparable results. Each value is the mean  SD for 6 independent cultures. *P< 0.05, experimental group
vs. Wnt10b-Ab treated group; #P< 0.05, experimental group vs. untreated control.
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Since the inhibition of Wnt ligand binding by addition
of Wnt Ab to the culture medium did reduce, but, as
noted for ALP-speciﬁc activity, not completely inhibit
the PTH-induced eﬀects, a Wnt ligand-independent
activation of the Wnt receptors LRP5/638 and sup-
pressed production of sclerostin, which acts as an
inhibitor of the Wnt signaling pathway, also have to
be considered.9,39,40 Another possibility is that, in add-
ition to Wnt10b, PTH may induce the secretion of sev-
eral other Wnt ligands.
Interestingly, regarding proliferation and early
osteoblastic diﬀerentiation, co-culture with T cells
seemed to sensitize hPDL cells for the subsequent
PTH signaling, since the increase in cell number and
ALP activity was more intense in hPDL cells harvested
from co-cultures in comparison to monocultures.
However, this synergistic eﬀect was not visible for
osteocalcin expression as a marker of late diﬀerenti-
ation stages, indicating a diﬀerential response of
hPDL cells that underlines their unique characteristics
despite several features they share with osteoblasts.
In summary and in the attempt to put our ﬁndings
into a clinical perspective, there is considerable agree-
ment among all our data allowing for the conclusion
that in periodontal remodeling there is a crosstalk
between T cells and PDL cells involved in the mediation
of the anabolic PTH eﬀect. It results in an expansion of
the pool of hPDL cells present in the local microenvir-
onment that then further diﬀerentiate along the osteo-
blastic pathway and contribute to the regeneration of
periodontal tissues that were damaged or lost in the
course of inﬂammatory disease or dental measures
such as orthodontic tooth movement. This information
might be exploited in the future to reﬁne and amend
existing regenerative periodontal treatment strategies
founded on the anabolic properties of PTH and the
regulatory capacity of hPDL cells for the remodeling
of the local microenvironment.
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